Chemoradiotherapy for esophageal cancer: Current status and perspectives

International Journal of Clinical Oncology

Volumn 9, Issue 6, 2004, Pages 444-450

  Ohtsu, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Chemoradiotherapy; Combined modality treatment; Esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; PACLITAXEL; VINBLASTINE;

BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; HUMAN; INTERMETHOD COMPARISON; JAPAN; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; TREATMENT OUTCOME;

EID: 12444252998     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0454-9     Document Type: Review

References (51)

1. De-Ren S (1989) Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 16:329-334
2. Newaishy GA, Read GA, Duncan W, et al. (1982) Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin Radiol 33:347-352
3. Okawa T, Kita M, Tanaka M, et al. (1989) Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 17:49-54
4. Al-Sarraf M, Martz K, Herskovic A, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284
5. Coia LR, Minsky BD, John MJ, et al. (1998) Patterns of care study decision tree and management guidelines for esophageal cancer. Radiat Med 16:321-327
6. Wong RKS, Malthener RA, Zuraw L, et al. (2003) Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys 55:930-942
7. National Comprehensive Cancer Network Panel Members (2003). Esophageal cancer - clinical practice guidelines in oncology. J Natl Comp Cancer Network 1:14-27
8. Araujo CMM, Souhami L, Gil RA, et al. (1991) A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67:2258-2261
9. Slabber CF, Nel JS, Schoeman L, et al. (1998) A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cell cancer of the esophagus. Am J Clin Oncol 21:462-465
10. Smith TJ, Ryan LM, Douglass HO, et al. (1998) Combined chemoradiotherapy vs radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42: 269-276
11. Herscovic A, Martz LK, Al-Sarraf M, et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598
12. Cooper JS, Guo MD, Herscovic A, et al. (1999) Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281:1623-1627
13. Minsky BD, Pajak T, Ginsberg RJ, et al. (2002) INT 0123 (RTOG 94-05) phase III trial of combined modality therapy for esophageal cancer: high dose (64.8 Gy) vs standard dose (50.4 Gy) radiation therapy. J Clin Oncol 20:1167-1174
14. Muller JM, Erasmi H, Stelzner M, et al. (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77:845-857
15. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without pre-operative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359:1727-1733
16. Chan A, Wong A (1999) Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 45:265-270
17. Hironaka S, Ohtsu A, Boku N, et al. (2003) Non-randomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2-3NanyM0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425-433
18. Walsh T, Noonan N, Hollywood D, et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-167
19. Bosset J, Gignoux M, Sahmoud T, et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell carcinoma of the esophagus. N Engl J Med 337:161-167
20. Urba S, Orringer M, Turrisi A, et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305-313
21. Bedenne L, Michel P, Bouche O, et al. (2002) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol 21:130a (abstract 642)
22. Stahl M, Wilke H, Walz MK, et al. (2003) Randomized phase III trial in locally advanced squamous cell carcinoma (SCC) of the esophagus: chemoradiation with and without surgery. Proc Am Soc Clin Oncol 22:250a (abstract 1001)
23. Stahl M, Wilke H, Fink U, et al. (1996) Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J Clin Oncol 14:829-837
24. Stewart FM, Harkins BJ, Hahn SS, et al. (1989) Cisplatin, 5-fluorouracil, mitomycin C and concurrent radiation therapy with and without esophagectomy for esophageal carcinoma. Cancer 64:622-628
25. Hoff SJ, Stewart JR, Sawyers JL, et al. (1993) Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 56:282-287
26. Wright CD, Wain JC, Lynch TJ, et al. (1997) Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study. J Thorac Cardiovasc Surg 114:811-816
27. Ishikura S, Nihei K, Ohtsu A, et al. (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697-2702
28. Geh JI, Crellin AM, Glynne-Jones R (2001) Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 88:338-356
29. Ura T, Muro K, Shimada Y, et al. (2004) Definitive chemoradiotherapy may be standard treatment option in clinical stage I esophageal cancer. Proc Am Soc Clin Oncol 22:317s (abstract 4017)
30. Kato H, Udagawa H, Togo A, et al. (2003) A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma: the Japan Clinical Oncology Group study (JCOG 9708). Proc Am Soc Clin Oncol 21:286a (abstract 1147)
31. Igaki H, Kato H, Tachimori Y, et al. (2001) Clinicopathological characteristics of patients with clinical stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 20:1089-1094
32. Ando N, Ozawa S, Kitajima M, et al. (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225-232
33. Ando N, Iizuka T, Ide H, et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group study - JCOG 9204. J Clin Oncol 21:4592-4596
34. Japanese Committee for Registration of Esophageal Carcinoma Cases (1989) Parameters linked to 10-year survival in Japan of resected esophageal carcinoma. Chest 96:1005-1011
35. Akiyama H, Tsurumaru M, Udagawa H, et al. (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220:364-373
36. Baba M, Aikoh T, Yoshinaka H, et al. (1994) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the esophagus. Ann Surg 219:310-316
37. Ohtsu A, Boku N, Muro K, et al. (1999) Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915-2921
38. Mera K, Ohtsu A, Boku N, et al. (2001) Definitive chemoradiotherapy (CRT) for T4 squamous cell carcinoma of the esophagus. Proc Am Soc Clin Oncol 20:161a (abstract 642)
39. Kaneko K, Ito H, Mitamura K, et al. (2003) Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer 88:18-24
40. Nishimura Y, Suzuki M, Shigeoka H, et al. (2002) Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53:134-139
41. Grinsky T, Auperin A, Marsiglia H, et al. (1997) Accelerated fractionation in esophageal cancer: a multivariate analysis on 88 patients. Int J Radiat Oncol Biol Phys 38:1013-1018
42. Jeremic B, Shibamoto Y, Acimovic L, et al. (1998) Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 40:1061-1066
43. Wang Y, Shi XH, He SQ, et al. (2002) Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 54:131-136
44. Gray JR, Meruch AA, Kalman L, et al. (1999) Neoadjuvant paclitaxel/carboplatin/5FU/radiation therapy for localized esophageal cancer: update of a Minnie Pearl Cancer Research Network phase II trial. Proc Am Soc Clin Oncol 18:271a (abstract 1082)
45. Bonner JA, Harari PM, Giralt J, et al. (2004) Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: a phase III study of high dose radiotherapy with or without cetuximab. Proc Am Soc Clin Oncol 22:489a (abstract 5507)
46. Van Groeningen C, Richel D, Glaccone G, et al. (2004) Gefitinib phase II study in second-line treatment of advanced esophageal cancer. Proc Am Soc Clin Oncol 22:319a (abstract 4022)
47. Murakami M, Kuroda Y, Okamoto Y, et al. (1998) Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 40:1049-1059
48. Swisher SG, Wynn P, Putnam JB, et al. (2002) Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123:175-183
49. Nasierowska-Guttmejer A, Szawlowski A, Jastrzebska M, et al. (1999) p53 Protein accumulation as a prognostic marker of preoperative radiotherapy and/or chemotherapy in advanced squamous cell esophageal carcinoma - preliminary report. Dis Esophagus 12:128-131
50. Hironaka S, Hasebe T, Ohtsu A, et al. (2002) Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy. Clin Cancer Res 8:124-130
51. Hattori S, Muto M, Ohtsu A, et al. (2003) EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 58:65-70